How clear is Clearbridge Health post-listing outlook?

How clear is Clearbridge Health post-listing outlook?

PC Lee
14/12/17, 04:06 pm

SINGAPORE (Dec 14): Clearbridge Health (CBH), the healthcare firm which focuses on the delivery of precision medicine, boosts a capable team to lead its expansion across Asia, says Maybank KimEng.

See: Clearbridge Health to list on Catalist; seeking to raise $24.6 million

CBH is an early entrant in Asia metabolomics profiling, precision oncology testing and genetic-based screening tests. The company also provides a range of healthcare services, from primary preventive services to oncology diagnostic services.

Top management is helmed by CEO Jeremy Yee who has experience in other medical related business throughout Asia including stints as CEO of SGX-listed Cordlife Group and COO of ASX-listed Cordlife.

In conjunction with its listing, CBH is selling 88 million new shares at 28 cents each by way of placement. Of the $24.6 million raised, $11 million is earmarked for expansion of medical clinics and centres, $7.5 million for working capital and general corporate purposes and $3 million for expansion of lab testing services.

Markets eyed by CBH include the Philippines, Indonesia, Myanmar, India, Malaysia and China. CBH has already entered into a term sheet for the potential acquisitions of a medical centre in Philippines.

Based on its 481 million issued shares, CBH will have a market cap of $134.7 million immediately at listing. Major shareholders include Halcyon Investment Capital with a 24% stake, Johnson Chen with 15.7% stake, Maxim Vorobyev with 8.3% and Johnny Chen at 6.4%.

As for the risks, analyst John Cheong says CBH incurred a net loss of $2.1 million for FY16 ended Dec and $2.4 million for 1H17 with revenue coming in at $716,000 and $284,000 respectively. CBH also expects operating expenses to increase after listing.

CBH may also require extra funding to implement its long-term business strategies. It may not be able to raise finance in a favourable term. Also, shareholders might be diluted if CBH issues new shares or other securities, says Cheong.

Meanwhile, CBH operates in a highly regulated industry and its business is subject to extensive regulations, licensing and accreditation requirements. Compliance and violation might lead to additional costs and resources.

Skilled and qualified staff is required to operate and manage the laboratory and medical clinics/centres. CBH’s ability to attract, retain and motivate staff is also crucial.

CBH will start trading on Catalist on Dec 18.

Sasseur REIT rides on China's love for luxury goods

SINGAPORE (Apr 23): Following a site visit to Sasseur REIT’s outlet malls – Chongqing mall and Hefei mall – during their annual Spring sale, the REIT has attracted the attention of Phillip Capital. In an unrated report on Monday, analyst Natalie Ong says, “Sasseur’s outlet malls not only offer large discounts on branded goods targeted at the middle class, brand-conscious consumer, but also incorporate numerous activities and entertainment programmes to engage different age group.” According to Ong, luxury retail demand is expected to grow in China. Globally, Chinese consumers....

Don't demonise China but neither be its vassal state: Ho Kwon Ping

SINGAPORE (Apr 23): The current United States and China trade tensions, businessman Ho Kwon Ping thinks, is not about a trade war but about a paradigm shift towards China becoming a major global player who does not want to play by Western rules. Ho says: “The current US-China tensions are not only not about the trade war, it is not even about geopolitical or geo-economic rivalry. It is about an entire paradigm shift in civilisational relationships which has not happened for the last 200 to 300 years ever since the ascendancy of Western civilisation to become the dominant civilisation in t....

UOB KayHian remains positive as SPH turns to student accommodation to arrest flagging media business

SINGAPORE (Apr 23): Despite continued weakness in its core media business, UOB Kay Hian is staying positive on Singapore Press Holdings (SPH) on the back of its foray into the student accommodation segment. SPH last week announced it has acquired a portfolio of three purpose-built student accommodation (PBSA) assets in the UK for £134 million ($237 million). See: SPH expands UK student dorm portfolio with $237 mil acquisition The assets span three cities in the UK – Southampton, Sheffield and Leads – and has a total capacity of 1,243 beds, bringing SPH’s total portfolio to over....